Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew R Smith

Showing results (211-220 of 319) with videos related to

Pageof 32
Sort By:
The Oncologist|October 9, 2023
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS TrialNeal D Shore, Maha Hussain, Fred Saad, et al.
Future Oncology (London, England)|February 8, 2023
Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS studyNeal D Shore, Felipe Cruz, Luke Nordquist, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancerPhilip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancerArnold L Potosky, Reina Haque, Andrea E Cassidy-Bushrow, et al.
Nature Communications|February 1, 2025
The role of viral interaction in household transmission of symptomatic influenza and respiratory syncytial virusJessica C Ibiebele, Elie-Tino Godonou, Amy P Callear, et al.
Redox Biology|March 17, 2019
Mitochondria in precision medicine; linking bioenergetics and metabolomics in plateletsBalu K Chacko, Matthew R Smith, Michelle S Johnson, et al.
The New England Journal of Medicine|February 15, 2019
Darolutamide in Nonmetastatic, Castration-Resistant Prostate CancerKarim Fizazi, Neal Shore, Teuvo L Tammela, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic responseCharles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Clinical Pharmacokinetics|June 22, 2016
Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate CancerXu Steven Xu, Charles J Ryan, Kim Stuyckens, et al.
Computers in Biology and Medicine|May 15, 2026
Toward protocol simplification: Deep learning-based image synthesis in three-phase CT urographyHongkun Yu, Syed Jamal Safdar Gardezi, E Jason Abel, et al.
Pageof 32

Showing results (211-220 of 319) with videos related to

Sort By:
Pageof 32
The Oncologist|October 9, 2023
Efficacy and Safety of Darolutamide in Combination With Androgen-Deprivation Therapy and Docetaxel in Black Patients From the Randomized ARASENS TrialNeal D Shore, Maha Hussain, Fred Saad, et al.
Future Oncology (London, England)|February 8, 2023
Efficacy and safety of darolutamide in Black/African-American patients from the phase III ARAMIS studyNeal D Shore, Felipe Cruz, Luke Nordquist, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 15, 2024
The radiopharmaceutical radium-223 has immunomodulatory effects in patients and facilitates anti-programmed death receptor-1 therapy in murine models of bone metastatic prostate cancerPhilip J Saylor, Sergey V Kozin, Aya Matsui, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2014
Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancerArnold L Potosky, Reina Haque, Andrea E Cassidy-Bushrow, et al.
Nature Communications|February 1, 2025
The role of viral interaction in household transmission of symptomatic influenza and respiratory syncytial virusJessica C Ibiebele, Elie-Tino Godonou, Amy P Callear, et al.
Redox Biology|March 17, 2019
Mitochondria in precision medicine; linking bioenergetics and metabolomics in plateletsBalu K Chacko, Matthew R Smith, Michelle S Johnson, et al.
The New England Journal of Medicine|February 15, 2019
Darolutamide in Nonmetastatic, Castration-Resistant Prostate CancerKarim Fizazi, Neal Shore, Teuvo L Tammela, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Phase II study of abiraterone acetate in chemotherapy-naive metastatic castration-resistant prostate cancer displaying bone flare discordant with serologic responseCharles J Ryan, Shreya Shah, Eleni Efstathiou, et al.
Clinical Pharmacokinetics|June 22, 2016
Modeling the Relationship Between Exposure to Abiraterone and Prostate-Specific Antigen Dynamics in Patients with Metastatic Castration-Resistant Prostate CancerXu Steven Xu, Charles J Ryan, Kim Stuyckens, et al.
Computers in Biology and Medicine|May 15, 2026
Toward protocol simplification: Deep learning-based image synthesis in three-phase CT urographyHongkun Yu, Syed Jamal Safdar Gardezi, E Jason Abel, et al.
Pageof 32